With a market capitalization (market cap) of $1.27B — a measure of how much the company is worth — GoodRx Holdings, Inc. is the 2437th most valuable company in Healthcare as of August 18, 2026. Shares trade at $3.65, down +1.88% on the day.
of 2,587
price ÷ annual EPS
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
GoodRx Holdings, Inc. provides American consumers with essential resources and tools to compare and ultimately lower the cost of their prescription medications. The company operates a digital platform dedicated to price comparison, delivering customized, geographically tailored prescription pricing. It also grants access to special, negotiated rates through unique GoodRx codes, which can be utilized for savings on prescriptions throughout the entire United States. Beyond this core offering, the firm also extends its portfolio to include subscription services, programs designed for pharmaceutical manufacturers, and telehealth capabilities. GoodRx additionally collaborates with pharmacy benefit managers, entities responsible for managing drug formularies and overseeing prescription transactions, including the critical task of setting prices between consumers and pharmacies. The company was founded in 2015 and maintains its principal office in Santa Monica, California.
Visit websiteAs of August 18, 2026, GoodRx Holdings, Inc. (GDRX) is worth $1.27B — this is its market capitalization, the total value of all its outstanding shares.
GoodRx Holdings, Inc.’s market cap is $1.27B, which ranks it #2437 among the most valuable companies in the Healthcare sector tracked on MarketCapLens.
GoodRx Holdings, Inc. (GDRX) shares trade at $3.65, down 1.88% on the day, as of August 18, 2026.
GoodRx Holdings, Inc. trades at a price-to-earnings (P/E) ratio of 42.7, based on its latest share price and annual earnings per share.
Fundamentals are annual. Figures labeled with their fiscal year.
FY 2025